Trump Signs Executive Order Tying Grant Money to Free Speech

It’s unclear how the order, which charges academic institutions to follow existing rules regarding the First Amendment, will be implemented and enforced.

Written byCarolyn Wilke
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: President Trump delivers remarks prior to signing the executive order.
OFFICIAL WHITE HOUSE PHOTO BY JOYCE N. BOGHOSIAN, FLICKR

Yesterday (March 21), President Donald Trump issued an executive order requiring colleges and universities to protect free speech in exchange for federal research funds.

The order charges colleges and universities to follow existing free speech protections. It mandates public institutions to uphold the US Constitution’s First Amendment while private organizations that receive federal funding are to abide by their “stated institutional policies,” according to Inside Higher Ed.

The policy enlists the 12 federal agencies that issue grants, including the National Institutes of Health and the National Science Foundation, to work with the White House’s Office of Management and Budget “to ensure institutions that receive Federal research or education grants promote free inquiry,” according to Inside Higher Ed.

“We’re dealing with billions and billions and billions of dollars. . . . Taxpayer ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies